CRP and cancer: IL-6, similar to many core inflammatory factors, is increased by a large amount in the inflammatory microenvironment of cancer cells; this occurs through the induction of CRP, which activates the NF-κB pathway to reduce the activity of caspase-3 and inhibit the apoptosis of cancer cells [21].